Silverfin false false 31/03/2025 01/04/2024 31/03/2025 Mr D Jacobson 26/11/2024 Dr S H Jacobson 18/01/2017 30 October 2025 no description of principal activity 10570725 2025-03-31 10570725 bus:Director1 2025-03-31 10570725 bus:Director2 2025-03-31 10570725 2024-03-31 10570725 core:CurrentFinancialInstruments 2025-03-31 10570725 core:CurrentFinancialInstruments 2024-03-31 10570725 core:ShareCapital 2025-03-31 10570725 core:ShareCapital 2024-03-31 10570725 core:RetainedEarningsAccumulatedLosses 2025-03-31 10570725 core:RetainedEarningsAccumulatedLosses 2024-03-31 10570725 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-03-31 10570725 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-03-31 10570725 core:OfficeEquipment 2024-03-31 10570725 core:OfficeEquipment 2025-03-31 10570725 2023-03-31 10570725 core:AcceleratedTaxDepreciationDeferredTax 2025-03-31 10570725 core:AcceleratedTaxDepreciationDeferredTax 2024-03-31 10570725 2024-04-01 2025-03-31 10570725 bus:FilletedAccounts 2024-04-01 2025-03-31 10570725 bus:SmallEntities 2024-04-01 2025-03-31 10570725 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 10570725 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 10570725 bus:Director1 2024-04-01 2025-03-31 10570725 bus:Director2 2024-04-01 2025-03-31 10570725 core:DevelopmentCostsCapitalisedDevelopmentExpenditure core:TopRangeValue 2024-04-01 2025-03-31 10570725 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-04-01 2025-03-31 10570725 core:OfficeEquipment core:TopRangeValue 2024-04-01 2025-03-31 10570725 2023-04-01 2024-03-31 10570725 core:OfficeEquipment 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure

Company No: 10570725 (England and Wales)

HARLEY THERAPY PLATFORM LTD

Unaudited Financial Statements
For the financial year ended 31 March 2025
Pages for filing with the registrar

HARLEY THERAPY PLATFORM LTD

Unaudited Financial Statements

For the financial year ended 31 March 2025

Contents

HARLEY THERAPY PLATFORM LTD

COMPANY INFORMATION

For the financial year ended 31 March 2025
HARLEY THERAPY PLATFORM LTD

COMPANY INFORMATION (continued)

For the financial year ended 31 March 2025
DIRECTORS Mr D Jacobson (Appointed 26 November 2024)
Dr S H Jacobson
REGISTERED OFFICE 41 Great Portland Street
London
W1W 7LA
United Kingdom
COMPANY NUMBER 10570725 (England and Wales)
ACCOUNTANT S&W Partners LLP
Onslow House
Onslow Street
Guildford
GU1 4TL
HARLEY THERAPY PLATFORM LTD

BALANCE SHEET

As at 31 March 2025
HARLEY THERAPY PLATFORM LTD

BALANCE SHEET (continued)

As at 31 March 2025
Note 2025 2024
£ £
Fixed assets
Intangible assets 4 271,078 330,429
Tangible assets 5 6,902 7,279
277,980 337,708
Current assets
Debtors 6 6,175 7,057
Cash at bank and in hand 126,482 129,550
132,657 136,607
Creditors: amounts falling due within one year 7 ( 1,269,005) ( 1,386,705)
Net current liabilities (1,136,348) (1,250,098)
Total assets less current liabilities (858,368) (912,390)
Provision for liabilities 8 ( 69,495) ( 84,427)
Net liabilities ( 927,863) ( 996,817)
Capital and reserves
Called-up share capital 1 1
Profit and loss account ( 927,864 ) ( 996,818 )
Total shareholder's deficit ( 927,863) ( 996,817)

For the financial year ending 31 March 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Harley Therapy Platform Ltd (registered number: 10570725) were approved and authorised for issue by the Board of Directors on 30 October 2025. They were signed on its behalf by:

Dr S H Jacobson
Director
HARLEY THERAPY PLATFORM LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2025
HARLEY THERAPY PLATFORM LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Harley Therapy Platform Limited is a private limited company, limited by shares and registered in England and Wales. The company's registration number is 10570725 and its registered office address is 41 Great Portland Street, London, W1W 7LA.

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgement in applying the company's accounting policies.

The company's functional and presentational currency is GBP.

The following principal accounting policies have been applied:

Going concern

The financial statements have been prepared on a going concern basis.

The Director has carefully reviewed the future prospects of the company and has agreed to continue to support the company to meet its day to day working capital requirements, having assessed this the Director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future being at least the next 12 months from signing of these financial statements.

For this reason the director continues to adopt the going concern basis for the preparation of the Financial Statements. Accordingly, these financial statements do not include any adjustments to the carrying amount or classification of assets and liabilities that would result if the company was unable to continue as a going concern.

Turnover

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

Taxation

Current tax
The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current corporation tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the company operates and generates income.

Deferred tax
Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

The estimated useful lives range as follows:

Development costs 10 years straight line
Research and development

In the research phase of an internal project it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research shall be recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific criteria are met in order to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured. The capitalised development costs are subsequently amortised on a straight-line basis over their useful economic lives of 10 years.

If it is not possible to distinguish between the research phase and the development phase of an internal project, the expenditure is treated as if it were all incurred in the research phase only.

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Office equipment 3 years straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last
reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Trade and other debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Trade and other creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Financial instruments

The company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

Provisions

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.

Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.

Increases in provisions are generally charged as an expense to profit or loss.

2. Critical accounting judgements and key sources of estimation uncertainty

The only significant judgements that have had been made by the director in preparing these financial statements is the useful economic life of the company's intangible assets.

3. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the year, including directors 2 1

4. Intangible assets

Development costs Total
£ £
Cost
At 01 April 2024 593,511 593,511
At 31 March 2025 593,511 593,511
Accumulated amortisation
At 01 April 2024 263,082 263,082
Charge for the financial year 59,351 59,351
At 31 March 2025 322,433 322,433
Net book value
At 31 March 2025 271,078 271,078
At 31 March 2024 330,429 330,429

5. Tangible assets

Office equipment Total
£ £
Cost
At 01 April 2024 8,513 8,513
Additions 2,665 2,665
At 31 March 2025 11,178 11,178
Accumulated depreciation
At 01 April 2024 1,234 1,234
Charge for the financial year 3,042 3,042
At 31 March 2025 4,276 4,276
Net book value
At 31 March 2025 6,902 6,902
At 31 March 2024 7,279 7,279

6. Debtors

2025 2024
£ £
Trade debtors 6,175 7,057

7. Creditors: amounts falling due within one year

2025 2024
£ £
Trade creditors 4,063 14
Amounts owed to Group undertakings 1,177,327 1,327,327
Amounts owed to directors 74 74
Accruals 14,051 4,001
Corporation tax 38,250 31,908
Other taxation and social security 35,240 23,381
1,269,005 1,386,705

8. Deferred tax

2025 2024
£ £
At the beginning of financial year ( 84,427) ( 97,688)
Credited to the Profit and Loss Account 14,932 13,261
At the end of financial year ( 69,495) ( 84,427)

The deferred taxation balance is made up as follows:

2025 2024
£ £
Accelerated capital allowances ( 69,495) ( 84,427)

9. Related party transactions

Transactions with entities in which the entity itself has a participating interest

During the year companies which are 100% subsidiaries of the holding company were paid back £150,000 (2024: £200,000). Expenses incurred on behalf of Harley Therapy Platform £nil (2024: £102,670). Also included in creditors is £74 (2024: £74) owed to the director. The balance at the year end included within creditors is an amount of £1,177,327 (2024: £1,327,327) due to these companies, this amount is interest free and repayable on demand.

10. Ultimate controlling party

Parent Company:

Harley Therapy Holdings Ltd
41 Great Portland Street, London, W1W 7LA